Archive - March 2018
Verona’s RPL554 improves lung function in CF trial
Three Publicis Health agencies unveils new campaign
Publicis Health unveils new creative campaign
FDA to review Dupixent® (dupilumab) as potential treatment for moderate-to-severe asthma
Senate plans 340B oversight hearings as transparency push mounts
Sanofi files Dupixent for severe asthma
Mylan, Revance link to develop Botox biosimilar
Novartis, Pear to develop digital therapies for schizophrenia, MS